RiboBio-B (06938) Appoints Anders Gabrielsen as Chief Medical Officer and John Taylor as Chief Business Officer

Intelligent Finance APP, Ribo Life Science-B (06938) announced that Dr. Anders Gabrielsen has been appointed as the company's Chief Medical Officer, and will be responsible for the company’s overall clinical development, medical affairs, and regulatory compliance; Dr. John Taylor has been appointed as the company’s Chief Business Officer, and will be responsible for the company’s overall business development, licensing-in, out-licensing cooperation, and strategic investment; Dr. Gan Liming will no longer serve as Chief Medical Officer but will continue to serve as the company’s Executive Director, Co-Chief Executive Officer, and Global R&D President, all effective from March 25, 2026.